Health AI Advisory Strategy, validation, and guardrails
for medical & consumer products
for medical & consumer products
Linkedin
About SkyMedAI
The Practice
An advisory practice led by Dr. Amir Lahav, a former Harvard Medical School professor and digital health leader at Pfizer, with broad experience across healthcare, life sciences, and consumer health, trusted by a network of clinicians, scientists, investors, and entrepreneurs.
The Work
Helping companies turn visionary ideas into commercial success, from early strategy through market adoption and scale. Specialty areas include clinical validation, AI guardrails, and investment diligence for medical-grade and consumer health solutions.
The Philosophy
Dr. Lahav’s mantra shapes every advisory engagement:
“AI isn’t about brilliant algorithms,
it’s about basic ones used brilliantly.”
Brilliance isn’t inventing something new; it’s applying something simple in a way no one else saw, with proper validation and guardrails in place.
Target Industries
• Investors
• Health Systems
• Regulators & Payers
• Pharma & Life Sciences
• Patient Advocacy Groups
• Startups & Emerging Tech
• Medtech, Healthtech & BigTech
Core Advisory Expertise
• Clinical & Scientific Validation
• Medical Devices & Patient Apps
• Wearables & Digital Endpoints
• AI Safety for Medical & Consumer
• Pharma Commerical & Clinical Trials
• Investment Strategy & Due Diligence
• Product Development & GTM Strategy
The Advantage
• Scientific depth
• Clinical expertise
• Honesty over diplomacy
• Creative problem-solving
• Connections that open doors
• Agility to see what others miss
• Priority speaking at the DHAI Summit
Our Clients
Who We Work With
Every industry is different. So is our approach.
What People Say
Strategic Mindset & Vision
“Dr. Lahav rewires how you think. Each conversation brings clarity, foresight, and strategic lift. His instincts on partnerships and market shifts shape the direction we’re heading.”
John Gannon, President & CEO, Blue Spark Tech
Strong Network & Connections
”Amir’s network is a strategic weapon. His personal connections with key decision-makers, combined with SkyMedAI’s team, translate access into crucial intel and real value—exactly what founders need.”
Teri Chou, PhD, Founder & CEO, Modus Health
Expert Investor Guidance
”As a serial founder, I’ve worked with many advisors. Amir stands out for his strategic clarity, scientific depth, and market instinct that drive real results. He is the collaborator you need by your side when engaging investors.”
David Fox, Angel Investor, Co-founder, Modality.AI
Top Clinical Advisory
”Dr. Lahav is among the best clinical advisors I’ve worked with. He sees patterns in nontraditional datasets and turns them into strategic advantages. He crafts narratives that give founders the confidence to engage clinicians, investors, and partners.”
Micha Breakstone, PhD, Co-Founder & CEO, Somite
Deep Regulatory Expertise
”Most FDA rejections stem from poor strategy and communication failures. Amir’s special skill is precisely anticipating what regulators care about: what they need to hear, the data they must see, and how to secure approvals for digital health and AI products.”
Jonathan Helfgott, Former FDA Senior Leadership
Go-to-Market Confidence
”Amir and SkyMedAI were outstanding. Their sophisticated strategy, sharp attention to detail, and expert product positioning pushed us to think bigger. Their coaching completely changed how we showed up in the US market to secure partnerships.”
Roy Tal, Founder & CEO, Solo AI
Solutions & Expertise
Elite advisory driving the future of health.
↓ Click any card to explore ↓
Team
Amir Lahav
Mari Heghinian
Dennis Wall
Monica Isgut
Renae Beaumont
Arturo Loaiza-Bonilla
Precision Medicine & Oncology
Meagan Lauber
Jochen Hurlebaus
European Markets
Nadav Shimoni
Masako Amemiya
Adam Vogel
Tina Hernandez-Boussard
Gazal Vakili
Career Opportunities
Join us on the Human-AI frontier.
The DHAI Summit
Close
Close
Close